Integra LifeSciences (IART) Tops Q4 EPS by 1c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
February 25, 2016 4:01 PM ESTFourth Quarter Revenues Increased 10.1% to $241.2 Million Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39 Full Year Organic Revenues Increased 6.7%
PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) --  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the fourth quarter and full year ending December 31, 2015.Â
Highlights:Â
Fourth quarter revenue increased 10.1% over the prior year quarter to $241.2 million;Organic revenues increased 3.9% in the fourth quarter... More


